![Karin Lövgren-Bengtsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karin Lövgren-Bengtsson
Technik-/Wissenschafts-/F&E-Leiter bei Novavax AB
Profil
Karin Lövgren-Bengtsson is currently working as the Chief Scientific Officer at Novavax AB since 2010.
She has an educational background with undergraduate and doctorate degrees from the Swedish University of Agricultural Sciences.
Aktive Positionen von Karin Lövgren-Bengtsson
Unternehmen | Position | Beginn |
---|---|---|
Novavax AB
![]() Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 |
Ausbildung von Karin Lövgren-Bengtsson
Swedish University of Agricultural Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Novavax AB
![]() Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |